Heron Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRTX and other ETFs, options, and stocks.

About HRTX

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034.

CEO

Craig A. Collard

CEOCraig A. Collard

Employees

122

Employees122

Headquarters

Cary, North Carolina

HeadquartersCary, North Carolina

Founded

1983

Founded1983

Employees

122

Employees122

HRTX Key Statistics

Market cap

239.34M

Market cap239.34M

Price-Earnings ratio

-136.36

Price-Earnings ratio-136.36

Dividend yield

—

Dividend yield—

Average volume

1.39M

Average volume1.39M

High today

$1.38

High today$1.38

Low today

$1.30

Low today$1.30

Open price

$1.34

Open price$1.34

Volume

848.18K

Volume848.18K

52 Week high

$2.68

52 Week high$2.68

52 Week low

$1.04

52 Week low$1.04

HRTX News

TipRanks 23h

Heron Therapeutics Approves Stock Issuance Proposals

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own HRTX. This list is generated using Robinhood data, and it’s not a recommendation.